المؤلفون: Ruscito, I, Castillo-Tong, DC, Vergote, I, Ignat, I, Stanske, M, Vanderstichele, A, Ganapathi, RN, Glajzer, J, Kulbe, H, Trillsch, F, Mustea, A, Kreuzinger, C, Panici, PB, Gourley, C, Gabra, H, Kessler, M, Sehouli, J, Darb-Esfahani, S, Braicu, EI

المصدر: 225 ; 214

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, Ovarian cancer, CD133, ALDH1, Aldehyde dehydrogenase-1, Cancer stem-like cell, BRCA, Prognosis, Survival, ALDEHYDE DEHYDROGENASE 1, ALDH1 EXPRESSION, BRCA2 MUTATIONS, CLINICAL-TRIALS, POOR-PROGNOSIS, CHEMOTHERAPY, METAANALYSIS, MARKER, CARCINOMA, AC133 Antigen, Adult, Aged, Antineoplastic Agents, BRCA2 Protein, Biomarkers, Tumor, Clonal Evolution, Female, Humans

العلاقة: European Journal of Cancer; http://hdl.handle.net/10044/1/50572Test; https://dx.doi.org/10.1016/j.ejca.2017.04.016Test

الإتاحة: https://doi.org/10.1016/j.ejca.2017.04.016Test
http://hdl.handle.net/10044/1/50572Test

المؤلفون: Pierluigi Benedetti Panici, Jalid Sehouli, Ram N. Ganapathi, Hani Gabra, Charlie Gourley, Mirjana Kessler, Fabian Trillsch, Hagen Kulbe, Ilary Ruscito, Mandy Stanske, Adriaan Vanderstichele, Silvia Darb-Esfahani, Ignace Vergote, Elena Ioana Braicu, Dan Cacsire Castillo-Tong, Jacek Glajzer, Iulia Ignat, Caroline Kreuzinger, Alexander Mustea

المصدر: European Journal of Cancer
Ruscito, I, Cacsire Castillo-tong, D, Vergote, I, Ignat, I, Stanske, M, Vanderstichele, A, Ganapathi, R N, Glajzer, J, Kulbe, H, Trillsch, F, Mustea, A, Kreuzinger, C, Benedetti Panici, P, Gourley, C, Gabra, H, Kessler, M, Sehouli, J, Darb-esfahani, S & Braicu, E I 2017, ' Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy–Innovative Models Prolong Survival (OCTIPS) Consortium ', European Journal of Cancer, vol. 79, pp. 214-225 . https://doi.org/10.1016/j.ejca.2017.04.016Test

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Neoplasm, Residual, BRCA, ALDEHYDE DEHYDROGENASE 1, Platinum Compounds, Carcinoma, Ovarian Epithelial, aldehyde dehydrogenase-1, Somatic evolution in cancer, 0302 clinical medicine, AC133 Antigen, Neoplasms, Glandular and Epithelial, CD133, ALDH1 EXPRESSION, Ovarian Neoplasms, CHEMOTHERAPY, Middle Aged, 3. Good health, Isoenzymes, ovarian cancer, 030220 oncology & carcinogenesis, Neoplastic Stem Cells, Biomarker (medicine), Immunohistochemistry, Female, cancer stem-like cell, Life Sciences & Biomedicine, CLINICAL-TRIALS, Adult, medicine.medical_specialty, CARCINOMA, Ubiquitin-Protein Ligases, Antineoplastic Agents, Biology, survival, Aldehyde Dehydrogenase 1 Family, Clonal Evolution, 03 medical and health sciences, POOR-PROGNOSIS, Internal medicine, Biomarkers, Tumor, ALDH1, prognosis, Carcinoma, medicine, Humans, BRCA2 MUTATIONS, Oncology & Carcinogenesis, METAANALYSIS, Survival analysis, Aged, BRCA2 Protein, Science & Technology, Retinal Dehydrogenase, Cancer, medicine.disease, Survival Analysis, 030104 developmental biology, MARKER, Cancer cell, Neoplasm Recurrence, Local, Ovarian cancer, 1112 Oncology And Carcinogenesis

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7c591b8855a8485d92f18b17ef01e56Test
https://doi.org/10.1016/j.ejca.2017.04.016Test